These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 28357892)

  • 1. Suspected Synthetic Cannabinomimetic Intoxication: Case Series and Review.
    Baum RA; Bailey A; Chan R; Blumenschein K
    J Pharm Pract; 2018 Apr; 31(2):238-243. PubMed ID: 28357892
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthetic Cannabinoid Abuse in Adolescents: A Case Series.
    Besli GE; Ikiz MA; Yildirim S; Saltik S
    J Emerg Med; 2015 Nov; 49(5):644-50. PubMed ID: 26293411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe illness associated with reported use of synthetic cannabinoids: a public health investigation (Mississippi, 2015).
    Kasper AM; Ridpath AD; Gerona RR; Cox R; Galli R; Kyle PB; Parker C; Arnold JK; Chatham-Stephens K; Morrison MA; Olayinka O; Preacely N; Kieszak SM; Martin C; Schier JG; Wolkin A; Byers P; Dobbs T
    Clin Toxicol (Phila); 2019 Jan; 57(1):10-18. PubMed ID: 29989463
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delayed seizure-like activity following analytically confirmed use of previously unreported synthetic cannabinoid analogues.
    Schep LJ; Slaughter RJ; Hudson S; Place R; Watts M
    Hum Exp Toxicol; 2015 May; 34(5):557-60. PubMed ID: 25233895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute intoxication caused by synthetic cannabinoids 5F-ADB and MMB-2201: A case series.
    Barceló B; Pichini S; López-Corominas V; Gomila I; Yates C; Busardò FP; Pellegrini M
    Forensic Sci Int; 2017 Apr; 273():e10-e14. PubMed ID: 28190538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic cannabinoid "Black Mamba" infidelity in patients presenting for emergency stabilization in Colorado: a P SCAN Cohort.
    Brandehoff N; Adams A; McDaniel K; Banister SD; Gerona R; Monte AA
    Clin Toxicol (Phila); 2018 Mar; 56(3):193-198. PubMed ID: 28862050
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential physiological and behavioral cues observed in individuals smoking botanical marijuana versus synthetic cannabinoid drugs.
    Chase PB; Hawkins J; Mosier J; Jimenez E; Boesen K; Logan BK; Walter FG
    Clin Toxicol (Phila); 2016; 54(1):14-9. PubMed ID: 26653952
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute kidney injury associated with smoking synthetic cannabinoid.
    Buser GL; Gerona RR; Horowitz BZ; Vian KP; Troxell ML; Hendrickson RG; Houghton DC; Rozansky D; Su SW; Leman RF
    Clin Toxicol (Phila); 2014 Aug; 52(7):664-73. PubMed ID: 25089722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxicological findings of synthetic cannabinoids in recreational users.
    Kronstrand R; Roman M; Andersson M; Eklund A
    J Anal Toxicol; 2013 Oct; 37(8):534-41. PubMed ID: 23970540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature Review.
    Altintop I; Karakukcu C
    Behav Sci (Basel); 2018 Sep; 8(10):. PubMed ID: 30248995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic cannabinoid use: recognition and management.
    Castellanos D; Thornton G
    J Psychiatr Pract; 2012 Mar; 18(2):86-93. PubMed ID: 22418399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of synthetic cannabinoids in patients with psychotic disorders: case series.
    Celofiga A; Koprivsek J; Klavz J
    J Dual Diagn; 2014; 10(3):168-73. PubMed ID: 25392292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Marijuana poisoning.
    Fitzgerald KT; Bronstein AC; Newquist KL
    Top Companion Anim Med; 2013 Feb; 28(1):8-12. PubMed ID: 23796481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical and financial implications of emergency department visits for synthetic marijuana.
    Rowley E; Benson D; Tiffee A; Hockensmith A; Zeng H; Jones GN; Musso MW
    Am J Emerg Med; 2017 Oct; 35(10):1506-1509. PubMed ID: 28457767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthetic Cannabinoids: Psychopharmacology, Clinical Aspects, Psychotic Onset.
    Martinotti G; Santacroce R; Papanti D; Elgharably Y; Prilutskaya M; Corazza O
    CNS Neurol Disord Drug Targets; 2017; 16(5):567-575. PubMed ID: 28412921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiotoxicity associated with the synthetic cannabinoid, K9, with laboratory confirmation.
    Young AC; Schwarz E; Medina G; Obafemi A; Feng SY; Kane C; Kleinschmidt K
    Am J Emerg Med; 2012 Sep; 30(7):1320.e5-7. PubMed ID: 21802885
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical Illness Secondary to Synthetic Cannabinoid Ingestion.
    Kourouni I; Mourad B; Khouli H; Shapiro JM; Mathew JP
    JAMA Netw Open; 2020 Jul; 3(7):e208516. PubMed ID: 32687586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical toxicity following analytically confirmed use of the synthetic cannabinoid receptor agonist MDMB-CHMICA. A report from the Identification Of Novel psychoActive substances (IONA) study.
    Hill SL; Najafi J; Dunn M; Acheampong P; Kamour A; Grundlingh J; Blain PG; Thomas SH
    Clin Toxicol (Phila); 2016 Sep; 54(8):638-43. PubMed ID: 27251903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuropsychiatric Sequelae in Adolescents With Acute Synthetic Cannabinoid Toxicity.
    Anderson SAR; Oprescu AM; Calello DP; Monte A; Dayan PS; Hurd YL; Manini AF;
    Pediatrics; 2019 Aug; 144(2):. PubMed ID: 31285395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Signs and symptoms associated with synthetic cannabinoid toxicity: systematic review.
    Courts J; Maskill V; Gray A; Glue P
    Australas Psychiatry; 2016 Dec; 24(6):598-601. PubMed ID: 27558216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.